Catalyst Pharmaceuticals (CPRX) Current Taxes (2023 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Current Taxes of $19.6 million for Q1 2026, up 1305.87% on a QoQ basis from $1.4 million in Q4 2025, and up 77.02% year-over-year from $11.1 million in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Current Taxes (2023 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Current Taxes history runs 4 years deep, the most recent figure standing at $19.6 million for Q1 2026.
- Quarterly Current Taxes rose 77.02% year-over-year to $19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (up 77.02% YoY) and the FY2025 annual result came in at $1.4 million, up 56.15% from the prior year.
- Current Taxes was $19.6 million for Q1 2026 at Catalyst Pharmaceuticals, up from $1.4 million in the prior quarter.
- Across five years, Current Taxes topped out at $19.6 million in Q1 2026 and bottomed at $15000.0 in Q2 2024.
- A 4-year average of $4.4 million and a median of $811500.0 in 2023 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2024 — Current Taxes gained 22.63% — and 2025, when it surged 2826.67%.
- Catalyst Pharmaceuticals' Current Taxes stood at $729000.0 in 2023, then climbed by 22.63% to $894000.0 in 2024, then surged by 56.15% to $1.4 million in 2025, then soared by 1305.87% to $19.6 million in 2026.
- Business Quant data shows CPRX's Current Taxes at $19.6 million in Q1 2026, $1.4 million in Q4 2025, and $710000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 19.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.63 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 710,000.00 |
| Jun 30, 2025 | 439,000.00 |
| Mar 31, 2025 | 11.09 Mn |
| Dec 31, 2024 | 894,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Dec 31, 2023 | 729,000.00 |